Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa

a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients

NCT01361009 ·Status: COMPLETED

Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease

NCT00240409 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease

NCT01470859 ·Status: COMPLETED ·Phase: NA

Pivotal Study in Advanced Parkinsons Disease Patients

NCT00466167 ·Status: COMPLETED ·Phase: PHASE3

Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole

NCT02236728 ·Status: COMPLETED

A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia.

NCT00903838 ·Status: TERMINATED ·Phase: PHASE2

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

NCT00601523 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients

NCT00479401 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease

NCT02172573 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients

NCT00402233 ·Status: COMPLETED ·Phase: PHASE4

Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms

NCT00297778 ·Status: COMPLETED ·Phase: PHASE4

Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment

NCT00651183 ·Status: COMPLETED

Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease

NCT02906488 ·Status: COMPLETED

Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical Practice

NCT01061567 ·Status: COMPLETED

Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease

NCT00666653 ·Status: COMPLETED ·Phase: PHASE1

Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease

NCT02233023 ·Status: COMPLETED ·Phase: PHASE4

Pramipexole Extended Release Versus Pramipexole Immediate Release for 18 Weeks in Chinese Parkinson's Disease (PD) Patients

NCT01191944 ·Status: COMPLETED ·Phase: PHASE3

Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease

NCT01673724 ·Status: COMPLETED ·Phase: PHASE4

A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)

NCT01294800 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate in Patients With Parkinsonian Type Disorders

NCT03683225 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.

NCT03845387 ·Status: COMPLETED ·Phase: PHASE2

The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa

NCT03521635 ·Status: COMPLETED ·Phase: PHASE4

A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease

NCT01494532 ·Status: COMPLETED ·Phase: PHASE4

Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients

NCT02073981 ·Status: COMPLETED

Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease

NCT00558025 ·Status: COMPLETED ·Phase: PHASE3